PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, VTRS, and UTHR
Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Viatris (VTRS), and United Therapeutics (UTHR).
Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.
Prestige Consumer Healthcare has a net margin of 18.60% compared to Prestige Consumer Healthcare's net margin of 10.50%. Prestige Consumer Healthcare's return on equity of 15.85% beat Inter Parfums' return on equity.
Inter Parfums presently has a consensus price target of $178.67, indicating a potential upside of 47.83%. Prestige Consumer Healthcare has a consensus price target of $91.25, indicating a potential upside of 44.43%. Given Prestige Consumer Healthcare's stronger consensus rating and higher possible upside, equities research analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.
55.6% of Inter Parfums shares are owned by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Inter Parfums shares are owned by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Inter Parfums has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500.
Prestige Consumer Healthcare received 38 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 64.41% of users gave Inter Parfums an outperform vote.
Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inter Parfums had 10 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 12 mentions for Inter Parfums and 2 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 0.61 beat Inter Parfums' score of 0.45 indicating that Inter Parfums is being referred to more favorably in the media.
Summary
Inter Parfums beats Prestige Consumer Healthcare on 13 of the 18 factors compared between the two stocks.
Get Prestige Consumer Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prestige Consumer Healthcare Competitors List
Related Companies and Tools
